Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Tom Fong, MD, Kim Trinkaus, PhD, Douglas R. Adkins, MD, Ravi Vij, MD, Steven Devine, MD, Michael Tomasson, MD, Lawrence T. Goodnough, MD, Timothy Graubert, MD, Shalini Shenoy, MD, John F. DiPersio, MD, PhD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 1800.

https://doi.org/10.1182/blood.V106.11.1800.1800

Published: 2005

Journal Articles

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Linda A. Verkruyse, MD, Aarti Oza, Steven M. Devine, MD, Douglas R. Adkins, MD, Hanna Khoury, MD, John F. DiPersio, MD, Ravi Vij, MD

Blood (2004) 104 (11): 3158.

https://doi.org/10.1182/blood.V104.11.3158.3158

Published: 2004

Journal Articles

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Geoffrey L. Uy, M.D., Nicholas M. Fisher, B.S., Steven M. Devine, M.D., Hanna J. Khoury, M.D, Douglas R. Adkins, M.D., Michael H. Tomasson, M.D, Timothy A. Graubert, M.D., John F. DiPersio, M.D., Ph.D., Ravi Vij, M.D.

Blood (2004) 104 (11): 541.

https://doi.org/10.1182/blood.V104.11.541.541

Published: 2004

Journal Articles

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Peter Westervelt, Randy A. Brown, Douglas R. Adkins, Hanna Khoury, Peter Curtin, David Hurd, Selina M. Luger, Margaret K. Ma, Timothy J. Ley, John F. DiPersio

Blood (2001) 98 (2): 266–271.

https://doi.org/10.1182/blood.V98.2.266

Published: 2001

Journal Articles

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Douglas R. Adkins, Lawrence T. Goodnough, Shalini Shenoy, Randy Brown, Jennifer Moellering, Hanna Khoury, Ravi Vij, John DiPersio

Blood (2000) 95 (11): 3605–3612.

https://doi.org/10.1182/blood.V95.11.3605

Published: 2000

NARROW

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only